APSR2026-437

 
Late-Breaking
Submitted
Poster Presentation
 
AP14-010
P29
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1220469-46904-APSR26 Poster Template Ayaho Ueno宗先生校閲後版(pdfgear.com)_433122.pdf
Format: PDF Only
08. Lung Cancer
11

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Ayaho Ueno * Osaka Metropolitan University Department of Thoracic Surgery Osaka Japan
Shinjiro Mizuguchi - Osaka Metropolitan University Department of Thoracic Surgery Osaka Japan
Hirotaka Kinoshita - Osaka Metropolitan University Department of Thoracic Surgery Osaka Japan
Takuya Tanimura - Osaka Metropolitan University Department of Thoracic Surgery Osaka Japan
Satoshi Suzuki - Osaka Metropolitan University Department of Thoracic Surgery Osaka Japan
Kantaro Hara - Osaka Metropolitan University Department of Thoracic Surgery Osaka Japan
Hidetoshi Inoue - Osaka Metropolitan University Department of Thoracic Surgery Osaka Japan
Satoshi Okada - Osaka City General Hospital Department of Thoracic Surgery Osaka Japan
Kyukwang Chung - Osaka City General Hospital Department of Thoracic Surgery Osaka Japan
Takuma Tsukioka - Osaka City General Hospital Department of Thoracic Surgery Osaka Japan
Junichi Soh - Osaka Metropolitan University Department of Thoracic Surgery Osaka Japan
 
 
 
 
Presenting Author Details
Ayaho
Ueno
ayaho.f.0927@gmail.com
+819069702724
31-40
Japan
Original Research
Local rather than distant failure is associated with survival differences between T3 and T4 NSCLC ≥5 cm after upfront surgery: A multicenter study
Maximum 25 words
Abstract Content
Tumor size is an established prognostic factor in non–small cell lung cancer (NSCLC), and tumors ≥5 cm are generally associated with poorer outcomes. Although the TNM classification distinguishes T3 (5–7 cm) and T4 (>7 cm), it remains unclear what drives the difference in survival between these groups, particularly in patients undergoing upfront surgery. We aimed to examine recurrence patterns and their relationship with survival in NSCLC ≥5 cm without adjacent organ invasion.
We retrospectively analyzed 228 patients with NSCLC ≥5 cm who underwent curative-intent resection without neoadjuvant therapy at multiple institutions between 2006 and 2017. Patients with pathological invasion of adjacent organs or incomplete resection were excluded. Patients were categorized into T3 (n=128) and T4 (n=100) groups. Overall survival (OS) and recurrence patterns were compared between groups.
The median age was 69 years, and 184 patients were male. Lobectomy was performed in 139 patients, and extended resection—including pneumonectomy, bilobectomy, bronchovascular reconstruction, or chest wall resection—was performed in 89 patients. Baseline characteristics were comparable between groups. The 5-year OS was lower in the T4 group than in the T3 group (41% vs. 57%; p=0.004). Distant recurrence rates were similar between groups, irrespective of surgical extent. In contrast, local recurrence was more frequent in T4 tumors, particularly among patients undergoing lobectomy. In subgroup analyses, no clear difference in OS was observed between T3 and T4 among patients undergoing extended resection (p=0.293), whereas among those treated with lobectomy, T4 tumors were associated with worse OS than T3 tumors (42% vs. 68%; p=0.008).
In patients with NSCLC ≥5 cm without adjacent organ invasion undergoing upfront surgery, differences in survival between T3 and T4 disease appear to be related, at least in part, to local failure rather than distant recurrence. These findings suggest that improving local control may be important, and they provide a rationale for further evaluation of neoadjuvant systemic approaches, particularly in T4 disease.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Non–small cell lung cancer,Large tumor,Neoadjuvant therapy
maximum 3 keywords and no abbreviations, separated by commas
 
323